FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312142445> ?p ?o ?g. }

• W4312142445 abstract "Head and neck mucosal melanoma (HNMM) is a rare and aggressive subtype of melanoma. HNMM often develops as a recurrent or metastatic disease, and its prognosis is worse than that of cutaneous melanoma. Recent large-scale clinical studies have reported favorable outcomes with immune checkpoint inhibitors (ICIs) for melanoma. However, these clinical trials included only a small number of HNMM cases. This study aimed to estimate treatment outcomes and prognostic predictors of ICIs for advanced HNMM.Cases of advanced HNMM, defined as unresectable or metastatic HNMM at the initial diagnosis (five patients) or development of recurrent/metastatic HNMM after initial treatment (27 patients), were included in this study. Survival analysis and a search for prognostic factors were performed for these 32 patients. Furthermore, the detailed clinical course of patients who received ICI treatment was investigated.The median overall survival (OS) of 32 patients with advanced HNMM was 25.3 months. The estimated 1-, 3-, and 5-year OS rates were 68.4%, 42.8%, and 34.3%, respectively. Fourteen patients (43.7%) received ICIs, whereas 18 (56.3%) did not. Univariate analysis showed that ICI treatment was the only factor associated with a better 1-year OS. Patients who received ICI treatment had significantly longer OS (median OS: not reached, 1-year OS: 85.7%) than those who did not (median OS: 11.3 months, 1-year OS: 54.5%). The overall response and disease control rates of patients who received ICI treatment were 50% and 64.3%, respectively. Patients who achieved complete response (CR) or partial response (PR) to ICI treatment survived significantly longer (1-year OS: 100%) than those who did not (1-year OS: 71.4%). Among the five patients who discontinued ICI treatment due to severe immune-related adverse events (irAEs), four did not receive salvage treatments but showed durable treatment effects and survived for 9.8-54.2 months at the end of the follow-up period.ICI treatment achieved a favorable OS for advanced HNMM. CR/PR to ICI treatment and discontinuation owing to severe irAEs were favorable predictors of OS." @default.
• W4312142445 created "2023-01-04" @default.
• W4312142445 creator A5004014477 @default.
• W4312142445 creator A5005739505 @default.
• W4312142445 creator A5012399069 @default.
• W4312142445 creator A5027880928 @default.
• W4312142445 creator A5039131561 @default.
• W4312142445 creator A5040128306 @default.
• W4312142445 creator A5064109932 @default.
• W4312142445 creator A5065106305 @default.
• W4312142445 creator A5068079253 @default.
• W4312142445 creator A5074947008 @default.
• W4312142445 creator A5075740151 @default.
• W4312142445 creator A5089399243 @default.
• W4312142445 date "2022-12-26" @default.
• W4312142445 modified "2023-09-30" @default.
• W4312142445 title "Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease" @default.
• W4312142445 cites W1545177819 @default.
• W4312142445 cites W1908245140 @default.
• W4312142445 cites W1984372402 @default.
• W4312142445 cites W1988218503 @default.
• W4312142445 cites W2019607817 @default.
• W4312142445 cites W2059944384 @default.
• W4312142445 cites W2068237418 @default.
• W4312142445 cites W2089536793 @default.
• W4312142445 cites W2121960517 @default.
• W4312142445 cites W2128035403 @default.
• W4312142445 cites W2152897456 @default.
• W4312142445 cites W2154841567 @default.
• W4312142445 cites W2160766792 @default.
• W4312142445 cites W2166662937 @default.
• W4312142445 cites W2336393770 @default.
• W4312142445 cites W2397962830 @default.
• W4312142445 cites W2502134830 @default.
• W4312142445 cites W2526495974 @default.
• W4312142445 cites W2553340100 @default.
• W4312142445 cites W2560367415 @default.
• W4312142445 cites W2563228955 @default.
• W4312142445 cites W2572174216 @default.
• W4312142445 cites W2591717879 @default.
• W4312142445 cites W2733884328 @default.
• W4312142445 cites W2742667260 @default.
• W4312142445 cites W2743762084 @default.
• W4312142445 cites W2752227448 @default.
• W4312142445 cites W2785613599 @default.
• W4312142445 cites W2903486314 @default.
• W4312142445 cites W2928025315 @default.
• W4312142445 cites W2964213468 @default.
• W4312142445 cites W2981451730 @default.
• W4312142445 cites W2982223317 @default.
• W4312142445 cites W2983664422 @default.
• W4312142445 cites W2997114910 @default.
• W4312142445 cites W3001173873 @default.
• W4312142445 cites W3026275561 @default.
• W4312142445 cites W3120070433 @default.
• W4312142445 cites W3134716541 @default.
• W4312142445 cites W3200556565 @default.
• W4312142445 cites W4225302909 @default.
• W4312142445 cites W4290772423 @default.
• W4312142445 doi "https://doi.org/10.3389/fsurg.2022.1032626" @default.
• W4312142445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37082097" @default.
• W4312142445 hasPublicationYear "2022" @default.
• W4312142445 type Work @default.
• W4312142445 citedByCount "0" @default.
• W4312142445 crossrefType "journal-article" @default.
• W4312142445 hasAuthorship W4312142445A5004014477 @default.
• W4312142445 hasAuthorship W4312142445A5005739505 @default.
• W4312142445 hasAuthorship W4312142445A5012399069 @default.
• W4312142445 hasAuthorship W4312142445A5027880928 @default.
• W4312142445 hasAuthorship W4312142445A5039131561 @default.
• W4312142445 hasAuthorship W4312142445A5040128306 @default.
• W4312142445 hasAuthorship W4312142445A5064109932 @default.
• W4312142445 hasAuthorship W4312142445A5065106305 @default.
• W4312142445 hasAuthorship W4312142445A5068079253 @default.
• W4312142445 hasAuthorship W4312142445A5074947008 @default.
• W4312142445 hasAuthorship W4312142445A5075740151 @default.
• W4312142445 hasAuthorship W4312142445A5089399243 @default.
• W4312142445 hasBestOaLocation W43121424451 @default.
• W4312142445 hasConcept C121608353 @default.
• W4312142445 hasConcept C126322002 @default.
• W4312142445 hasConcept C141071460 @default.
• W4312142445 hasConcept C143998085 @default.
• W4312142445 hasConcept C144301174 @default.
• W4312142445 hasConcept C2777658100 @default.
• W4312142445 hasConcept C2777701055 @default.
• W4312142445 hasConcept C2779134260 @default.
• W4312142445 hasConcept C2781186586 @default.
• W4312142445 hasConcept C2781433595 @default.
• W4312142445 hasConcept C2994587330 @default.
• W4312142445 hasConcept C3018411727 @default.
• W4312142445 hasConcept C38180746 @default.
• W4312142445 hasConcept C502942594 @default.
• W4312142445 hasConcept C535046627 @default.
• W4312142445 hasConcept C71924100 @default.
• W4312142445 hasConceptScore W4312142445C121608353 @default.
• W4312142445 hasConceptScore W4312142445C126322002 @default.
• W4312142445 hasConceptScore W4312142445C141071460 @default.
• W4312142445 hasConceptScore W4312142445C143998085 @default.
• W4312142445 hasConceptScore W4312142445C144301174 @default.
• W4312142445 hasConceptScore W4312142445C2777658100 @default.

• next